US Patent Issued to GlaxoSmithKline Biologicals on Jan. 20 for "Methods for manufacturing a liposome encapsulated RNA" (Belgian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,742, issued on Jan. 20, was assigned to GlaxoSmithKline Biologicals S.A. (Rixensart, Belgium).

"Methods for manufacturing a liposome encapsulated RNA" was invented by Laurent Bernard Jean Strodiot (Rixensart, Belgium) and Geraldine Minet (Rixensart, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for manufacturing a non-viral delivery system comprising a liposome encapsulating an RNA using a microfluidic device and compositions for use therein are provided."

The patent was filed on May 30, 2018, under Application No. 16/617,016.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netac...